Models of Physiology and Physiologically Based Models in Clinical Pharmacology

被引:9
|
作者
Atkinson, A. J., Jr. [1 ]
Smith, B. P. [2 ]
机构
[1] Northwestern Univ, Dept Mol Pharmacol & Biochem, Feinberg Sch Med, Chicago, IL 60611 USA
[2] Amgen Inc, Biostat Med Sci, Thousand Oaks, CA USA
关键词
KINETICS; CIRCULATION; PHARMACOKINETICS; HETEROGENEITY; AGENTS; BLOOD; FLOW;
D O I
10.1038/clpt.2012.67
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
As science matures, it becomes more mathematical, progressing from enumeration to the use of equations to the formulation of models. Clinical pharmacology has developed to the stage where models play an increasingly important role in predicting and analyzing drug pharmacokinetics and pharmacodynamics, and even in characterizing disease progression and therapeutic response. Useful models have two characteristics that are in ostensible conflict: (i) they must accurately represent the essential features of the underlying system and (ii) the representation must be sufficiently simplified to enable its salient features to be identified and investigated through further experimentation.
引用
收藏
页码:3 / 6
页数:4
相关论文
共 50 条
  • [31] Integration of dissolution into physiologically-based pharmacokinetic models III: PK-Sim®
    Willmann, Stefan
    Thelen, Kirstin
    Lippert, Joerg
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2012, 64 (07) : 997 - 1007
  • [32] Pregnancy-specific physiologically-based toxicokinetic models for bisphenol A and bisphenol S
    Gingrich, Jeremy
    Filipovic, David
    Conolly, Rory
    Bhattacharya, Sudin
    Veiga-Lopez, Almudena
    ENVIRONMENT INTERNATIONAL, 2021, 147
  • [33] Chronic kidney disease and physiologically based pharmacokinetic modeling: a critical review of existing models
    Zamir, Ammara
    Alqahtani, Faleh
    Rasool, Muhammad Fawad
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2024, 20 (1-2) : 95 - 105
  • [34] Physiologically based pharmacokinetic models for the optimization of antiretroviral therapy: recent progress and future perspective
    Siccardi, Marco
    Rajoli, Rajith Kumar Reddy
    Curley, Paul
    Olagunju, Adeniyi
    Moss, Darren
    Owen, Andrew
    FUTURE VIROLOGY, 2013, 8 (09) : 871 - 890
  • [35] Evaluation of the predictive performance of physiologically based pharmacokinetic models for intramuscular injections of therapeutic proteins
    Chow, Timothy W.
    Wright, Matthew R.
    Hop, Cornelis E. C. A.
    Wong, Harvey
    XENOBIOTICA, 2019, 49 (12) : 1423 - 1433
  • [36] Use of physiologically based pharmacokinetic models to evaluate the impact of intestinal glucuronide hydrolysis on the pharmacokinetics of aglycone
    Wu, Baojian
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2012, 101 (03) : 1281 - 1301
  • [37] Application of physiologically-based pharmacokinetic/pharmacodynamic models to evaluate the interaction between nifedipine and apatinib
    Liu, Hongrui
    Yu, Yiqun
    Liu, Lu
    Wang, Chunyan
    Guo, Nan
    Wang, Xiaojuan
    Xiang, Xiaoqiang
    Han, Bing
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [38] A computer-aided framework for development, identification and management of physiologically-based pharmacokinetic models
    Heitzig, Martina
    Linninger, Andreas A.
    Sin, Gurkan
    Gani, Rafiqul
    COMPUTERS & CHEMICAL ENGINEERING, 2014, 71 : 677 - 698
  • [39] Utility of physiologically based pharmacokinetic models to drug development and rational drug discovery candidate selection
    Theil, FP
    Guentert, TW
    Haddad, S
    Poulin, P
    TOXICOLOGY LETTERS, 2003, 138 (1-2) : 29 - 49
  • [40] Physiology, pharmacology and parasitology
    Hennessy, DR
    INTERNATIONAL JOURNAL FOR PARASITOLOGY, 1997, 27 (02) : 145 - 152